# Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea

> **NCT03667222** · PHASE2 · UNKNOWN · sponsor: **BioPharmX, Inc.** · enrollment: 207 (actual)

## Conditions studied

- Papulopustular Rosacea

## Interventions

- **DRUG:** minocycline topical gel
- **DRUG:** topical gel vehicle

## Key facts

- **NCT ID:** NCT03667222
- **Lead sponsor:** BioPharmX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-18
- **Primary completion:** 2019-05-17
- **Final completion:** 2019-08-17
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2019-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03667222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03667222, "Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03667222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*